Healthcare Innovation April 4, 2024
Pietje Kobus

HHS publishes a white paper on policy considerations to address drug shortages

In an April 2 press release, the U.S. Department of Health and Human Services (HHS) announced the release of a white paper titled Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States. The paper outlines steps HHS has taken to prevent drug shortages. Additionally, the paper highlights solutions for policymakers.

“Hospitals can spend at least $600 million per year managing shortages,” the white paper reads. Shortages of life-saving drugs are a concern for patient care, health, and safety. According to HHS, there has been a shortage of 123 drugs as of January.

A new coordinator role has been established to help HHS...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, HHS, Pharma, Pharma / Biotech
New York’s 1332 Waiver Extends Affordable Coverage to Additional Groups
HHS' final rule to combat disability discrimination: What healthcare leaders should know
HHS Finalizes Antidiscrimination Rules On Patient Care Decision Tools, Including AI
Medical research is changing, data privacy laws have not
J&J,, BMS set to appeal losses in IRA drug pricing lawsuits

Share This Article